Among the companies with shares expected to actively trade in
Thursday's session are Bed Bath & Beyond Inc. (BBBY), Rite Aid
Corp. (RAD) and EBay Inc. (EBAY).
Bed Bath & Beyond's fiscal fourth-quarter earnings fell 11%
as the home-furnishings retailer recorded a drop in sales. Shares
fell 5.2% to $64.35 premarket.
Rite Aid's its fiscal fourth-quarter earnings fell 55%, despite
continued revenue growth, owing to impacts of one-time items such
as inventory-accounting adjustments and debt-extinguishment
charges. Shares rose 8.3% to $6.93 in recent premarket trading, as
adjusted earnings topped expectations and Rite Aid's fiscal-year
revenue guidance topped Wall Street views. Shares rose 12% to $7.16
premarket.
EBay reached a deal with Carl Icahn to settle their proxy
dispute, ending an contentious battle between the billionaire
activist investor and e-commerce company. EBay said Mr. Icahn is
withdrawing both his proposal to separate the company's PayPal
business and his two nominees to the company's board. Additionally,
eBay said it has agreed to Mr. Icahn's suggestion to appoint
business executive David Dorman as an independent director. Shares
fell 1.4% to $55.15 premarket.
Cash America International Inc. (CSH) said its board authorized
management to explore strategic options, including a possible
spinoff of its online lending business Enova International Inc. The
U.S.-based operator of pawn shops and check-cashing centers also
raised its per-share profit guidance for the first quarter thanks
to lower consumer- loan losses at the online business, as well as
improved sales and operating efficiencies at its storefront retail
business. Shares rose 13% to $43.60 premarket.
Chevron Corp. (CVX) said its first-quarter global oil and gas
production is expected to drop from the year-ago quarter, as poor
weather led to downtime in the U.S., Canada and other regions.
Shares fell 1.3% to $117.50 premarket.
Family Dollar Stores Inc. (FDO) said Thursday that it plans to
close about 370 stores and lower prices on nearly 1,000 basic items
as part of its effort to improve its financial performance. The
move comes as the company also reported weaker-than-expected fiscal
second-quarter earnings. Family Dollar's profit declined 35%, in
part because of inclement winter weather that kept shoppers at
home. Shares rose 43 cents to $59.50 premarket.
Shares of Imperva Inc. (IMPV) slumped Wednesday after the
data-center security provider trimmed its first-quarter
expectations due to order delays, particularly in the U.S. Shares
fell 35% to $32.40 premarket.
Ruby Tuesday Inc. (RT) swung to a fiscal third-quarter loss amid
weaker same-store sales and customer traffic. Still, revenue topped
Wall Street's expectations. Shares rose 5.7% to $6.30
premarket.
Watch List:
Abercrombie & Fitch Co. (ANF) named Joanne Crevoiserat as
the teen apparel retailer's executive vice president and chief
financial officer, the latest executive change that has come in
recent months.
AngioDynamics Inc. (ANGO) swung to a fiscal third-quarter profit
on stronger revenue that was led by the medical-equipment company's
peripheral vascular and oncology/surgery segments. For the fiscal
year, AngioDynamics lowered its estimate for adjusted per-share but
raised its revenue guidance.
Apogee Enterprises Inc.'s (APOG) fiscal fourth-quarter profit
jumped 83% as the glass-products designer reported rising sales and
gross margins.
Biogen Idec (BIIB) and Swedish Biovitrum AB, or Sobi, said a
Phase 3 study of a treatment for severe hemophilia A in children
under 12 years old has achieved its primary objectives.
Bristol-Myers Squibb Co. (BMY) said its late-stage study of a
hepatitis C treatment achieved positive results in up 90% of
certain patient groups, showing the efficacy of the drug
combination. The pharmaceutical firm is studying the use of two
drugs, daclatasvir and asunaprevir, among patients infected with
genotype 1b hepatitis C.
Leucadia National Corp. (LUK) Chief Financial Officer Joseph
Orlando will retire later this year because of health issues, the
financial holding company said Wednesday.
Write to John Kell at john.kell@wsj.com and Lauren Pollock at
lauren.pollock@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires